Abstract：Objective: To explore the glutathione S-transferase P-1 (GSTP1) genotype and its clinical significance in patients with colorectal cancer. Methods: The data of 80 patients with colorectal cancer diagnosed in Qinhuangdao First Hospital who agreed to undergo genetic testing were retrospectively selected. According to the GSTP1 gene situation, it is divided into gene mutation group (GSTP1 gene mutation) and gene wild type group (GSTP1 gene wild type). The blood samples and tissue samples of the patients were collected and sent to the Precision Medicine Department of our hospital for GSTP1 expression detection, and test results and the clinical and pathological characteristics of the patients were statistically analyzed. All patients were treated with chemotherapy, and the clinical efficacy, toxic and side effects, and progression-free survival were compared between the two groups. A sum of 18 tissue samples were selected to detect the expression of GSTP1 gene in colorectal cancer and adjacent tissues. Results: The GSTP1 gene detection of 80 patients showed that 35 cases were mutant (gene mutation group) and 45 cases were wild type (gene wild type group). There were no significant differences in the types, histological types, depth of invasion, nerve invasion, vascular tumor thrombus, and lymph node metastasis (P>0.05). The wild-type group (66.67%), with the difference being statistically significant (P<0.05); there was no significant difference in the occurrence of toxic and side effects between the two groups (P>0.05); the follow-up patients in the progression-free survival period gene mutation group [( 4.39±1.24) years] was significantly lower than that of the wild-type group [(6.49±2.15) years], with the difference being statistically significant (P<0.05); the relative expression of GSTP1 mRNA in colorectal cancer tissues was significantly higher than that in adjacent tissues, and the difference was statistically significant (P<0.05). Conclusion: The positive expression rate of GSTP1 gene in colorectal cancer tissues is high, and the chemotherapy effect and prognosis of patients with GSTP1 gene wild type are better than those of gene mutation patients. Clinically, prognostic evaluation and treatment plan selection should be combined with the patient's GSTP1 genotype.
宣斌, 王益民. 结直肠癌患者的GSTP1基因类型及其临床意义[J]. 河北医学, 2022, 28(10): 1655-1658.
XUAN Bin, WANG Yimin. The Effect of GSTP1 Gene on Colorectal Cancer and Its Significance. HeBei Med, 2022, 28(10): 1655-1658.
[1] 田传鑫,赵磊.结直肠癌及结直肠癌肝转移流行病学特点[J].中华肿瘤防治杂志,2021,28(13):1033-1038. [2] 吕雪琰,毕新宇,赵宏,等.新辅助化疗未达客观缓解的结直肠癌肝转移后续治疗方案的比较:直接手术或二线化疗后手术[J].中华外科杂志,2022,60(5):455-461. [3] 张杰,李昌海,李林子,等.DPYD、GSTP1、MTHFR基因多态性对5-FU类基础化疗结直肠癌患者疗效的影响[J].山东医药,2020,60(10):9-12,36. [4] 陈岷,张远,边原,等.结直肠癌患者UMPS酶基因多态性与氟尿嘧啶化疗敏感性及毒性相关性研究[J].医药导报,2022,41(6):869-873. [5] 张钟予,马一杰,邓文英,等.MTHFR、GSTP1、MSH3和ABCG1单核苷酸多态性与结直肠癌辅助化疗疗效和不良反应的相关性研究[J].胃肠病学和肝病学杂志,2019,28(3):301-306. [6] 黄喜文,蓝永权,杨志君.DPYD和GSTP基因多态性对结直肠癌患者术后辅助化疗XELOX方案相关毒性的影响[J].中国现代普通外科进展,2021,24(8):660-662,666. [7] 陈小恩,林白浪.GSTP1基因多态性与直肠癌化疗短期疗效及毒副反应的关系[J].现代消化及介入诊疗,2019,24(1):24-28. [8] Puerta-Garcia E,Urbano-Perez D,Carrasco-Campos MI,et al.Effect of DPYD,MTHFR,ABCB1,XRCC1,ERCC1 and GSTP1 on chemotherapy related toxicity in colorectal carcinoma[J].Surg Oncol,2020,35(14):388-398. [9] 张泽绪,张力文,唐丽艳,等.结直肠癌发病风险与GSTP1基因多态性的关系[J].中华实验外科杂志,2021,38(3):576. [10] Deng X,Hou J,Deng Q,et al.Predictive value of clinical toxicities of chemotherapy with fluoropyrimidines and oxaliplatin in colorectal cancer by DPYD and GSTP1 gene polymorphisms[J].World Surg Oncol,2020,18(1):321.
2022, Vol. 28 
冀公网安备13080202000786号